Cargando…
In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
AIMS: Hepatitis B Virus (HBV) infection is the major risk factor for hepatocellular carcinoma (HCC) in East Asia. Here we aimed to further investigate the abundance of viral antigen and DNA within HBV-related HCC and surrounding tissues at histological level. METHOD: In addition to routine histopath...
Autores principales: | Zheng, Ye, Xu, Mingzhu, Zeng, Dong, Tong, Haitao, Shi, Yuhan, Feng, Yanling, Zhang, Xiaonan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761330/ https://www.ncbi.nlm.nih.gov/pubmed/35034659 http://dx.doi.org/10.1186/s13000-022-01194-8 |
Ejemplares similares
-
Clinical relevance of the in situ assay for HBV DNA: a cross-sectional study in patients with chronic hepatitis B
por: Liu, Danping, et al.
Publicado: (2020) -
Evaluation of the in situ assay for HBV DNA: An observational real-world study in chronic hepatitis B
por: Li, Chang, et al.
Publicado: (2021) -
Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990) -
Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma
por: Yang, Liu, et al.
Publicado: (2018) -
New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
por: Lim, Young-Suk
Publicado: (2023)